Unlock Insights with our White Papers.
Dive deeper into industry trends, research, and gain valuable knowledge.
Get the latest data and expert insights at your fingertips. Discover, learn, and stay ahead in your field.
This white paper addresses the critical need for early diagnosis of Alzheimer's disease (AD) and the challenges of detecting it before symptoms appear. Researchers from Durin Technologies, Rowan University, and Brown University explore the potential of blood-based autoantibodies (aABs) as biomarkers for AD using Luminex xMAP® microspheres.
Just fill out the simple form to the right to download the Blood-Based Biomarkers to Aid Early Detection of Alzheimer’s Disease Pathology with Luminex white paper.
